208 related articles for article (PubMed ID: 8911142)
1. Cytotoxic activity against tumour cells mediated by intermediate TCR cells in the liver and spleen.
Kawamura T; Kawachi Y; Moroda T; Weerasinghe A; Iiai T; Seki S; Tazawa Y; Takada G; Abo T
Immunology; 1996 Sep; 89(1):68-75. PubMed ID: 8911142
[TBL] [Abstract][Full Text] [Related]
2. Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages.
Nakano Y; Hisaeda H; Sakai T; Ishikawa H; Zhang M; Maekawa Y; Zhang T; Takashima M; Nishitani M; Good RA; Himeno K
Microbes Infect; 2002 Jan; 4(1):1-11. PubMed ID: 11825769
[TBL] [Abstract][Full Text] [Related]
3. Natural cell-mediated cytotoxicity (NCMC) against NK-sensitive tumours in vitro by murine spleen Ly-6C+ natural T cells.
Martiniello R; Burton RC; Smart YC
Int J Cancer; 1997 Feb; 70(4):450-60. PubMed ID: 9033654
[TBL] [Abstract][Full Text] [Related]
4. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
5. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
Koyasu S
J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
[TBL] [Abstract][Full Text] [Related]
7. Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells.
Watanabe H; Miyaji C; Kawachi Y; Iiai T; Ohtsuka K; Iwanage T; Takahashi-Iwanaga H; Abo T
J Immunol; 1995 Sep; 155(6):2972-83. PubMed ID: 7673715
[TBL] [Abstract][Full Text] [Related]
8. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
[TBL] [Abstract][Full Text] [Related]
10. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
11. Mouse liver T cells: their change with aging and in comparison with peripheral T cells.
Tsukahara A; Seki S; Iiai T; Moroda T; Watanabe H; Suzuki S; Tada T; Hiraide H; Hatakeyama K; Abo T
Hepatology; 1997 Aug; 26(2):301-9. PubMed ID: 9252138
[TBL] [Abstract][Full Text] [Related]
12. Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment.
Ohtsuka K; Yasunami Y; Ikehara Y; Nagai T; Kodama S; Maki T; Tomita A; Abo T; Ikeda S
Transplantation; 1997 Aug; 64(4):633-9. PubMed ID: 9293878
[TBL] [Abstract][Full Text] [Related]
13. Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules.
Moroda T; Iiai T; Suzuki S; Tsukahara A; Tada T; Nose M; Hatakeyama K; Seki S; Takeda K; Watanabe H; Abo T
Immunology; 1997 Jun; 91(2):219-26. PubMed ID: 9227320
[TBL] [Abstract][Full Text] [Related]
14. Characterization of intermediate TCR cells in the liver of mice with respect to their unique IL-2R expression.
Watanabe H; Iiai T; Kimura M; Ohtsuka K; Tanaka T; Miyasaka M; Tsuchida M; Hanawa H; Abo T
Cell Immunol; 1993 Jul; 149(2):331-42. PubMed ID: 8330313
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
Koide J; Rivas A; Engleman EG
J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
[TBL] [Abstract][Full Text] [Related]
16. Relative resistance of intermediate TCR cells to anti-CD3 mAb in mice in vivo and their partial functional characterization.
Tsuchida M; Iiai T; Watanabe H; Abo T
Cell Immunol; 1992 Nov; 145(1):78-90. PubMed ID: 1423648
[TBL] [Abstract][Full Text] [Related]
17. IL-4 producing CD4+ TCR alpha beta int liver lymphocytes: influence of thymus, beta 2-microglobulin and NK1.1 expression.
Emoto M; Emoto Y; Kaufmann SH
Int Immunol; 1995 Nov; 7(11):1729-39. PubMed ID: 8580071
[TBL] [Abstract][Full Text] [Related]
18. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
19. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
[TBL] [Abstract][Full Text] [Related]
20. Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
Ferrini S; Cambiaggi A; Cantoni C; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
Int J Cancer Suppl; 1992; 7():15-8. PubMed ID: 1428398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
